Analysis of Free Drug Content in Antibody-Drug Conjugate Using 2D-LC/Q-TOF

Poster Reprint ASMS 2025 Poster number TP 003 Analysis of Free Drug Content in AntibodyDrug Conjugate Using 2D-LC/Q-TOF/MS Yulan Bian, Andreas Mielcarek Agilent Technologies, Inc. Introduction Antibody-drug conjugates (ADCs) are complex therapeutic biomolecules composed of an antibody linked to a…

Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes Application compendium Contents Introduction3 Featured application notes 2 PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mAbs and ADC (5991-7163EN) 5 Intact- and Peptide-Level Characterization of Trastuzumab Emtansine In Vitro…

Application Note Biopharma/Pharma Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS Authors David L. Wong and Sarah M. Stow Agilent Technologies, Inc. Abstract Antibody drug conjugates (ADCs), which comprise a monoclonal antibody (mAb) conjugated to a small molecule drug…

Consumables Workflow Ordering Guide Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods Antibody Drug Conjugates Antibody-drug conjugates (ADCs) represent a new generation of targeted biotherapeutics that make up a rapidly growing segment of the drug discovery pipeline.…